Hydroxychloroquine Improves Obesity-Associated Insulin Resistance and Hepatic Steatosis by Regulating Lipid Metabolism

The burden of obesity and associated cardiometabolic diseases has been considered as an important risk factor for lupus patients. Therefore, whether obesity is involved in the over-activation of autoimmune response has attracted more and more attention. Hydroxychloroquine is a synthetic antimalarial...

Full description

Saved in:
Bibliographic Details
Published in:Front Pharmacol
Main Authors: Qiao, Xin, Zhou, Zhuo-Chao, Niu, Rui, Su, Yu-Tong, Sun, Yue, Liu, Hong-Lei, Teng, Jia-Lin, Ye, Jun-Na, Shi, Hui, Yang, Cheng-De, Cheng, Xiao-Bing
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2019
Subjects:
Pharmacology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6689966/
https://ncbi.nlm.nih.gov/pubmed/31427967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.00855
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items